Removal of Antiretroviral Products from the WHO List of Prequalified Medicines
Information and Guidance for Regulatory Bodies, National AIDS Programmes, Doctors and Patients
ANNEX 1: ALTERNATIVE PREQUALIFIED MEDICINES AND SUPPLIERS
Lamivudine 150 mg plus zidovudine 300 mg tablet (GSK), blister (60), bottle (60)
Lamivudine 150 mg plus zidovudine 300 mg tablet (Hetero), blister (10), bottle (60)
Lamivudine 150mg plus stavudine 40 mg and nevirapine 200 mg tablet (CIPLA), bottle (60)
Lamivudine 150mg plus stavudine 30 mg and nevirapine 200 mg tablet (CIPLA), bottle (60)
Lamivudine 150 mg tablet (GSK), 10 mg/ml oral solution (GSK), bottle (60) and bottle (240 ml), respectively
Lamivudine 150 mg tablet (Hetero), blister (10), bottle (60)
Lamivudine 150 mg tablet (Strides), blister (10), bottle (60)